Create Medic (5187) Q2 2024 earnings summary

Executive summary

• Net sales for the quarter ended June 2024 rose 4.6% year-over-year to ¥6,300 million.

• Operating profit declined 13.3% year-over-year to ¥291 million.

• Profit attributable to owners of parent surged 73.9% year-over-year to ¥550 million.

• Comprehensive income more than doubled year-over-year, reaching ¥1,411 million.

Financial highlights

• Ordinary profit decreased 6.8% year-over-year to ¥345 million.

• Basic earnings per share increased to ¥61.35 from ¥34.78 year-over-year.

• Total assets as of June 2024 were ¥20,010 million, up from ¥15,869 million at December 2023.

• Net assets rose to ¥19,258 million from ¥14,944 million at December 2023.

• Capital adequacy ratio improved to 79.3% from 77.6% at December 2023.

Outlook and guidance

• Full-year net sales forecast for 2024 is ¥13,032 million, up 3.5% year-over-year.

• Operating profit forecast is ¥868 million, up 8.1% year-over-year.

• Ordinary profit forecast is ¥900 million, up 3.1% year-over-year.

• Profit attributable to owners of parent forecast is ¥967 million, up 527.8% year-over-year.

• Basic earnings per share forecast is ¥106.22.